Thomas L. Petty, M.D.
Professor of Medicine,
Chairman, National Lung Health Education Program (NLHEP)
The message in this month's communication was inspired by the Ninth International Conference on Lung Cancer, which I attended in Tokyo, Japan, in
The pharmaceutical industry has responded to the challenge of lung cancer by developing new drugs to offer a new window of hope for suffering patients. Progress is being made, and meaningful survival for the majority of patients suffering from advanced stages of lung cancer is now an emerging reality.
Today, we have the knowledge and technology which could change the face of lung cancer. The answer is early identification which greatly
I will be in touch next month.
Published: Jan 31 2002